U.S. Specialized REITs Stock News

Recent earnings forecasts for Brinker International (EAT) have drawn attention, with analysts expecting higher EPS and revenue for the June 2026 quarter and signaling a possible beat versus current consensus estimates. See our latest analysis for Brinker International. At a share price of US$227.27, Brinker International has seen strong momentum, with a 30 day share price return of 29.65% and a 90 day share price return of 63.88%, while the 3 year total shareholder return of almost 5x points...

Forward Air stock is ripping higher, up about 16% in early trading to around US$17.80 after its latest earnings. Short term traders are cheering record quarterly operating revenue of US$673 million and the strongest consolidated earnings before interest, tax, depreciation and amortization in roughly two and a half years. The bigger story sits on the income statement. The company still reported a sizeable quarterly loss, and trailing twelve month earnings remain deeply in the red. The market...

Trump Media & Technology Group recently launched Truth API, a paid data service giving institutional clients faster access to posts from high-profile Truth Social accounts, while also scheduling its inaugural earnings call for August 10, 2026, to discuss June-quarter results. This first move into data licensing has drawn political and ethics scrutiny over potential market conflicts of interest, putting the company’s monetization approach and governance practices under closer investor...

Dycom Industries (DY) is drawing fresh attention after appointing David J. Fallon and Michael C. Lenz to its Board of Directors on August 4, 2026, expanding the board from nine to eleven members. See our latest analysis for Dycom Industries. Despite the recent board appointments, Dycom Industries’ momentum has eased in the short term, with the share price down 4.2% over the past week and 6.7% over 90 days. Its 1 year total shareholder return of 44.6% and 5 year total shareholder return of...

In recent weeks, Tech Mahindra announced a partnership with Cisco to deliver an AI-driven Security Service Edge platform, while Intrado Life & Safety disclosed that its Emergency Routing Service is now integrated with Cisco-managed Webex Calling Multi-Tenant, enhancing cloud-based E911 compliance and safety for distributed workforces. These collaborations highlight how Cisco is embedding security and compliance deeper into its networking and collaboration platforms, potentially strengthening...

Niagen Bioscience recently announced that Tru Niagen®, a leading healthy-aging NAD+ supplement, became available on Walmart.com, expanding its reach through one of the United States’ largest digital retail platforms with initial 300 mg 30-count and 90-count offerings. A new peer-reviewed Aging Cell analysis linked Niagen’s nicotinamide riboside supplementation to reduced skeletal muscle epigenetic age acceleration, adding scientific weight to its healthy-aging positioning. Now we’ll examine...

Copa Holdings, S.A. recently reported past second-quarter 2026 results, with revenue rising to US$1,059.33 million while net income fell to US$68.18 million, alongside ratification of a third dividend of US$1.71 per share payable on September 15, 2026. The quarter highlighted the strain of much higher fuel prices on profitability even as Copa expanded capacity, strengthened traffic metrics, and continued rolling out Starlink onboard internet and new routes across its network. Now we’ll...

Zoetis stock has had a difficult run, with the share price down about 59.1% over the past five years, yet the current valuation checks still lean toward the shares looking cheap on several measures. Over the past five years, Zoetis has delivered a share price decline of about 59.1%, which puts long term holders firmly in negative territory and raises questions about what the current price already reflects. The recent appointment of James Saccaro as Chief Financial Officer and Chief Operating...

Why Ligand Pharmaceuticals Stock Is Back In Focus After Q2 Results Ligand Pharmaceuticals (LGND) is back on investor radar after Q2 2026 earnings, a completed royalty acquisition, fresh zero coupon convertible financing, and updated full year guidance released on August 6. See our latest analysis for Ligand Pharmaceuticals. The share price reaction to Ligand Pharmaceuticals' Q2 announcement has been mixed, with a 1 day share price return of a 0.8% decline and a 30 day share price return down...

McKesson stock barely flinched after earnings, slipping about 1% from its recent highs, even though the company just posted the kind of pharmaceutical distribution quarter that usually gets investors’ attention. Revenue reached about US$105.4b and adjusted earnings per share climbed 20% to US$9.93, with full year adjusted EPS guidance nudged higher. The market’s cool reaction appears at odds with those numbers. For now, traders appear to treat the move as a routine pause after a strong multi...

United States Antimony stock has delivered a very large 3 year return, yet the latest valuation work suggests the shares now sit close to intrinsic value while the broader checks still lean expensive. After such a strong run, investors are facing a stock that no longer screens as an obvious bargain. Over the past 3 years, United States Antimony has returned about 12x, which puts extra focus on whether recent gains already reflect the business outlook. Commissioning of the new Thompson Falls...

Sally Beauty Holdings (SBH) is back in focus after its third quarter earnings on 3 August 2026, which included slightly higher sales and net income along with a trim to full year net sales guidance. See our latest analysis for Sally Beauty Holdings. The third quarter update and slightly lower net sales guidance have come against a backdrop of improving momentum in Sally Beauty Holdings, with a 30 day share price return of 12.40% and a 1 year total shareholder return of 37.39%, even though the...

Why LyondellBasell Industries Stock Is Back in Focus LyondellBasell Industries (NYSE: LYB) is in the spotlight after reporting second quarter 2026 results, with sales of US$9,177 million and net income of US$558 million, alongside a buyback update showing no recent share repurchases. See our latest analysis for LyondellBasell Industries. The latest earnings release appears to have shifted sentiment toward LyondellBasell Industries, with a 1-month share price return of 12.53% and a year to...

In early August 2026, CVS Health reported second-quarter sales of US$35,117 million and revenue of US$106.10 billion, with net income rising to US$2,979 million and diluted EPS from continuing operations increasing to US$2.31. On the same day, CVS Health also raised its 2026 GAAP diluted EPS guidance and expanded its GLP-1 weight management offerings through a lower-cost MinuteClinic program and new Eli Lilly collaboration. Next, we’ll examine how CVS Health’s enhanced GLP-1 weight...

Barrick Mining (NYSE:B) has signed an exploration earn in and joint venture agreement with GreenLight Metals for the Kalium Canyon gold project in Nevada. The deal gives Barrick the option to earn a substantial interest in the project while acting as manager and operator. Barrick will fully fund the initial phases of exploration work at Kalium Canyon. The agreement expands Barrick Mining's presence in Nevada through a new gold exploration opportunity. This type of early stage partnership in...

In August 2026, BioCryst Pharmaceuticals reported second-quarter 2026 results showing revenue of US$218.25 million and net income of US$78.40 million, alongside raising its full-year 2026 total revenue guidance to a range of US$690 million to US$715 million. While the quarter was profitable, the company also disclosed a six‑month net loss of US$643.42 million, highlighting a sharp contrast between recent earnings momentum and the broader year-to-date financial picture. We’ll now explore how...

Ulta Beauty (ULTA) stock is drawing fresh attention after two new brand moves. Dr. Reju-All is launching in stores nationwide and online, alongside an exclusive Pacsun x Ulta Beauty fashion and beauty collaboration. See our latest analysis for Ulta Beauty. Against this backdrop of new brand launches and partnerships, Ulta Beauty’s share price has gained 18.73% over the past month, while the year to date share price return is down 13.10% and the 1 year total shareholder return is 6.44%. This...

Eli Lilly and Company recently reported second-quarter 2026 results, with revenue rising to about US$23.0 billion and net income to roughly US$7.10 billion, and raised its full-year 2026 revenue outlook to US$85.0 billion–US$87.0 billion. At the same time, Lilly is broadening its pipeline and manufacturing base through oncology collaborations, a Breakthrough Therapy designation for KRAS G12C inhibitor olomorasib, and expanded U.S. production capacity for injectable devices used in its...

StandardAero (SARO) is back on investor radar after reporting second quarter 2026 results that topped earnings and revenue expectations, with higher sales and net income drawing closer attention to the stock. See our latest analysis for StandardAero. Despite a brief pullback, with a 1 day share price return that declined 3.26% to US$30.00, StandardAero has a 90 day share price return of 19.33% and a 1 year total shareholder return of 6.42%. This suggests interest has been building around the...

Donnelley Financial Solutions recently reported its second-quarter and first-half 2026 results, with revenue rising to US$224.2 million and net income to US$36.4 million for the quarter, alongside higher earnings per share compared with the same period a year earlier. At the same time, the company completed a US$24.6 million repurchase of 540,897 shares, shrinking its share count and underscoring management’s continued use of buybacks as a capital allocation tool. We’ll now examine how the...

Red Rock Resorts (RRR) stock is in focus after the company reported second quarter 2026 results showing lower sales, revenue and earnings than a year earlier, while its board affirmed a quarterly cash dividend. See our latest analysis for Red Rock Resorts. Red Rock Resorts' share price has been choppy around the latest results, with a 1-day share price return of 3.18% contrasting with a 30-day share price return that is down 4.91%, while the 5-year total shareholder return of 86.05% points to...

In recent weeks, Rackspace Technology has faced multiple securities class action lawsuits alleging it misled investors about the impact of its pivot toward enterprise AI on its Private and Public Cloud businesses and full-year 2026 guidance. Amid this legal pressure, Rackspace also appointed former DigitalOcean and AWS executive Pranav Nambiar as Senior Vice President and General Manager, AI Infrastructure, signaling a deeper push into governed, compliant AI infrastructure for...

Medtronic stock has fallen about 21.2% over the past five years, yet current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach suggest the shares now sit close to what that cash flow model implies is fair value, while market multiples screen the company as undervalued. The roughly 21.2% share price decline over five years means long term holders have not been rewarded, which puts extra focus on whether today’s price fairly reflects Medtronic’s...

In early August 2026, Vaxcyte reported a second-quarter net loss of US$284.3 million and higher per-share losses, while also updating investors on its vaccine pipeline. The company’s completion of enrollment across three adult Phase 3 OPUS trials for VAX-31, alongside the first-in-human VAX-A1 study, underscores a rapid build-out of late- and early-stage programs despite rising costs. Next, we’ll examine how completing enrollment in the three VAX-31 Phase 3 OPUS trials could reshape...